Friday, January 25, 2019

New therapeutic target for graft-vs-host disease could make bone marrow transplant safer

Graft-versus-host disease (GVHD) is a major complication of bone marrow transplant, a potentially curative treatment for patients with blood-borne cancers such as leukemia and lymphoma. Inhibiting Sirt-1 in a mouse model helped control GVHD without making tumor relapse more likely, report researchers. The inhibitor has already been proven safe in humans but would need further testing in patients with blood-borne cancers.

from Top Health News -- ScienceDaily http://bit.ly/2DzHKsu
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover a protein switch that burns fat and blocks new fat cells

A protein called “Mitch” may hold the key to a new generation of obesity treatments. Researchers found that disabling it in human cells boos...